Jinwon Life Sciences Recruits Dr. Ka Mutumani as Chief Scientific Development Officer

Dr. Kar Muthumani

[Asia Economy Reporter Jang Hyowon] GeneOne Life Science announced on the 19th that it has appointed Dr. Kar Muthumani, a former researcher at the University of Pennsylvania and the Wistar Institute, as its Chief Scientific Development Officer.

The company explained, "The recruitment of Dr. Muthumani is part of a major expansion of our existing development capabilities in nucleic acid-based vaccine development for emerging infectious diseases, including COVID-19, as well as in immunology and oncology."

Dr. Muthumani developed groundbreaking vaccines against deadly and serious infectious diseases such as Human Immunodeficiency Virus (HIV), Chikungunya (CHIKV), Middle East Respiratory Syndrome (MERS), Zika (ZIKA), Mayaro, Powassan (POWV), and the COVID-19 (SARS-CoV-2) virus during his tenure at the University of Pennsylvania and the globally renowned Wistar Institute. His research team also developed numerous nucleic acid-based monoclonal antibody therapeutics for infectious diseases and cancer immunotherapy.

Park Young-geun, CEO of GeneOne Life Science, said, "We are very pleased to have Dr. Muthumani join our company. His 22 years of research and development experience in vaccine and immunotherapy development will greatly help solidify our company's expanding position in the DNA and RNA vaccine and therapeutic industry."

Dr. Muthumani stated, "I am delighted to join GeneOne Life Science, which is rapidly growing in the gene-based vaccine and therapeutic field. I believe the company's highly integrated product development system, from proof of concept to clinical research, and its significant achievements in emerging infectious diseases are among the best in the industry."

He added, "At GeneOne Life Science, I will do my best not only in the development of COVID-19 vaccines and therapeutics but also in the development of nucleic acid-based biopharmaceuticals and small molecule drugs for other urgent major diseases."